Upcoming Conferences
August Webinar
On-demand GLUT3 expression augments CAR-T cell metabolic fitness and antitumor efficacy in glioblastoma models
Join us for an insightful session with Dr. Keisuke Watanabe, Senior Staff Scientist in the Division of Cancer Immunology at National Cancer Center Japan, as he explores innovative approaches to improving CAR-T cell therapies for solid tumors.
In his webinar, Dr. Watanabe will share insights from his pioneering work in cellular immunotherapy and next-generation CAR-T development. With extensive experience spanning clinical care, translational research, and advanced immunology programs, his research focuses on overcoming key challenges in developing CAR-T therapies for difficult-to-treat cancers.
What You Will Learn
- Metabolic barriers limiting CAR-T cell performance in solid tumors
- The potential of GLUT3 to improve CAR-T cell fitness and persistence
- Novel engineering strategies to enhance antitumor efficacy in glioblastoma models
- Future directions for next-generation CAR-T therapies in non-B-cell malignancies
Speaker
Dr. Keisuke Watanabe
MD, PhD
Senior Staff Scientist, Division of Cancer Immunology, National Cancer Center Japan
Keisuke Watanabe, MD, PhD, is a Senior Staff Scientist in the Division of Cancer Immunology at the National Cancer Center Japan. He had dedicated over a decade to patient care, specializing in hematopoietic stem cell transplantation. Parallel to his clinical practice, he has spearheaded clinical research and translational research (TR) in cell therapy.
In 2015-2019, Dr. Watanabe was a postdoctoral fellow in the laboratory of Dr. Carl H. June at the Center for Cellular Immunotherapies at the University of Pennsylvania. There, he advanced the development of CAR-T cell therapies for T-cell malignancies and solid tumors, including combinatorial approaches with oncolytic viruses.
Since joining the National Cancer Center Japan in 2019, Dr. Watanabe has led various immunology programs. His current research focuses on developing CAR-T cells for non-B-cell malignancies, with a particular emphasis on AI-designed CARs to address the tonic signaling, CARs for T-cell tumors, and strategies to overcome metabolic checkpoints in the tumor microenvironment.
Date: 21 August 2026 | Friday
Venue: Virtual
WIC-APAC 2026
The 2026 World Immunotherapy Council Asia-Pacific Conference (WIC-APAC 2026), hosted in conjunction with the TSITC Annual Meeting and the TOS Spring Summit, brings together leading experts and the broader cancer immunotherapy community to share cutting-edge science, strengthen regional collaboration, and advance patient care across APAC.
Why Attend WIC-APAC 2026?
A regional gathering advancing cancer immunotherapy science, care, and collaboration across the Asia-Pacific.
Date: 28 – 29 March, 2026 | Sat – Sun
Venue: Taipei, Taiwan | Chang Yung-Fa Foundation (CYFF) International Convention Center
Visit Conference website: https://wicapac2026.org/
Conference Highlights
Scientific Program & Keynote sessions
Cross-disciplinary Collaboration
Early-Career & Young Investigator Opportunities
Networking & Community
Built on a Strong previous edition (WIC-APAC 2025)
Global Turnout
Around 200 participants
from 17+ countries
100% Top-Rated
Scientific content and speakers / faculty quality were rated excellent or good by all respondents
100% Recommend
100% of respondents would recommend this WIC-APAC to colleagues
90%+ Skills Boost
Over 90% reported increased professional competencies following the conference
International Surgical Oncology Symposium (ISOS 2026)
ISOS 2026 is a premier event dedicated to advancing the field of surgical oncology through education, collaboration, and innovation. This one-day symposium will strengthen the pipeline from discovery to bedside by integrating cutting-edge research, and clinical expertise.
29 August, 2026 | NUHS Auditorium | Singapore
Objectives:
1: Advance the field of peri-operative immunotherapy through education, collaboration and innovation.
2: Strengthen the surgical oncology pipeline from discovery to bedside, bridging research and clinical practice.
3: Integrate cutting-edge research with clinical expertise.
4: Foster collaboration among clinicians, researchers and innovators.
Contact Us:
- Braudon Yeo | Manager
- Direct: +65-6994-5464 or Office: +65 – 6994-5461 # 298
AP-SciBio2027 x WIC APAC 2027
AP-SciBio2027 × WIC-APAC2027 unite spatial biology and immunotherapy into a single, powerful platform.
Through international collaboration across the Asia-Pacific region, this joint meeting bridges high-resolution cellular and tissue maps with the real-world delivery of life-saving immunotherapies.
As part of the PEACE Symposia Pacific Series, the meeting convenes global leaders from academia, clinics, and industry to explore AI-decoded insights in tissue architecture, cellular ecosystems, and multi-omics—shaping the next era of precision science and medicine across the region and beyond.
25 – 27 February, 2027 | Bangkok, Thailand